Study Chairman News Today

a deal done. talks are at a sensitive points. we have live team coverage from jacqui heinrich and chad pergram. im sandra smith in for neil cavuto. this is "your world." we begin with jacqui at the white house. things look like theyre going to start happening here? >> well, sandra, theres a growing expectation well hear something from the president and from speaker mccarthy following this meeting set to happen here in 1 1/2 hours. after each side exchanged barbs over the weekend, biden...

- Company will also host a virtual analyst and investor event on November 13, 2023 ...

Eisenhower Presidential Library release:Abilene, Kan. - The public is invited to attend the August Lunch & Learn scheduled for&nbsp

KSAL is your number one source for salina local news, weather, sports, auctions.

Virtual Webinar to Take Place Friday, October 14th @ 11 AM ET Topline Results from ZETA-1 Phase 2b Trial of APX3330 Expected Later in 4Q 2022 FARMINGTON...

MILANO, Italy, Jan. 28, 2022 /PRNewswire/ -- FONDAZIONE Ricerca e Innovazione Cardiovascolare, Milano, focused on cardiovascular research, reports the first patient enrolment of the TRANSFORM

/PRNewswire/ -- FONDAZIONE Ricerca e Innovazione Cardiovascolare, Milano, focused on cardiovascular research, reports the first patient enrolment of the...

MILANO, Italy, Jan. 28, 2022 /PRNewswire/ -- FONDAZIONE Ricerca e Innovazione Cardiovascolare, Milano, focused on cardiovascular research, reports the first patient enrolment of the TRANSFORM II Randomized Controlled Trial (Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels) setting in motion a crucial trial in the Native Coronary Vessel Treatment domain. TRANSFORM II RCT, determined to explore and...

Oakville, Ontario--(Newsfile Corp. - January 19, 2022) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research

Highlights of Recent Positive Data from Nyxol's Phase 3 Registration Trial Roundtable Discussion by 3 KOLs with Unique Perspectives and Distinct Patient ...